Talking Precision Medicine - Genialis

Podcast details

Technical and general information from the podcast's RSS feed.

Site

RSS

Apple

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://www.linkedin.com/company/genialis
3 shares
https://www.linkedin.com/in/ryanfukushima/
1 share
https://www.linkedin.com/in/najat-khan-phd/
1 share

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

Publication history

Monthly episode publishing history over the past years.

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Zola-007: Giving T-cells the license to kill | Talking Precision Medicine #38

Season 7 · Episode 4

Thursday, August 29, 2024 • Duration 44:06

What a pleasure to sit down with my long time colleague and friend, Art Krieg, to discuss his latest venture, Zola Therapeutics, and his adventures in the great outdoors. Art has launched and exited a number of innovative biotechs, each time delving deeper into mechanisms by which we can harness the immune system for therapeutic purposes. Join us as we discuss how — despite a well earned retirement — the siren song that led to Zola was strong enough to get Art back in the game.

Episode 38 links:

Read moreCollapse

Cell therapy for T-cell malignancies—the science and business of developing curative medicines for patients in need | Talking Precision Medicine #37

Season 7 · Episode 3

Monday, July 22, 2024 • Duration 39:01

In this episode I chat with Dr Sarah Hein, co-founder and CEO of March Biosciences, a Houston Based biotech developing cell therapies for T-cell malignancies. Sarah is an old friend and colleague from our days as trainees at Baylor College of Medicine, where we both circulated among those with ambitions of entrepreneurship. Sarah has definitely made good in that regard, as a serial entrepreneur deeply enmeshed in Houston’s growing life sciences and healthtech ecosystem.

Episode 37 links:

Read moreCollapse

A new way to finance drug development, for rare disease and beyond | Talking Precision Medicine #28

Season 5 · Episode 3

Wednesday, November 30, 2022 • Duration 45:36

In this episode, our host and Genialis CEO Rafael Rosengarten spotlights Vibe Bio. Vibe Bio is a new biotech aiming to disrupt how we finance drug development through stakeholder communities and cryptocurrency, starting in the rare disease arena. Our guest is Alok Tayi, co-founder and CEO of Vibe. Alok is a successful serial entrepreneur and a rare disease community member.

Visit TPM E28 for highlights and links from this episode.

Read moreCollapse

What’s in a Name?: Endpoint Health’s Patient-Centric Northstar | Talking Precision Medicine #27

Season 5 · Episode 2

Monday, June 27, 2022 • Duration 43:16

This episode features Jason Springs, co-founder and CEO of Endpoint Health, an ascendant precision therapeutics company. Jason is a serial entrepreneur, who with the co-founders of his previous company, is building Endpoint Health to bring together under one roof the data science, diagnostics and therapeutics necessary to achieve truly personalized care.

Visit TPM E27 for highlights and links from this episode.

Read moreCollapse

Taking charge of your health future with wearables and AI | Talking Precision Medicine #26

Season 5 · Episode 1

Monday, February 28, 2022 • Duration 33:33

In this episode 26, our host Rafael sits down with Harry Glorikian. Harry is an investor, author, podcaster and veteran of the healthtech industry. Harry walks us through his latest book, The Future You, and expounds on the ways that wearable devices, personal health data and artificial intelligence are changing healthcare as we know it.

Visit TPM E26 for highlights and links from this episode.

Read moreCollapse

Real-Time Multiplexed Biomarkers: The Next Generation of Continuous Monitoring | Talking Precision Medicine #25

Season 4 · Episode 6

Sunday, September 5, 2021 • Duration 31:47

Earlier this summer, Rafael sat down with Peter Vranes and Hitesh Mehta, co-founders of Nutromics. Nutromics is developing a next generation lab-on-skin, a wearable device for continuous monitoring of health-critical biomarkers. Let’s get right to it.

Visit TPM 25 for highlights and links from this episode.

Read moreCollapse

Fostering Patient Journeys Around the World | Talking Precision Medicine #24

Season 4 · Episode 5

Wednesday, July 28, 2021 • Duration 40:42

Our guest is Dr. Angeli Moeller, Head of Pharma International Informatics at Roche. Angeli and our host, Rafael, discuss data science in the big pharma leagues; geek out on data standards; and dive deep on patient data rights and barriers to care.

Visit TPM E24 for highlights and links from this episode.

Read moreCollapse

From Cancer to Covid, Drug Intelligent Science at Breakneck Pace | Talking Precision Medicine #23

Season 4 · Episode 1

Friday, February 26, 2021 • Duration 47:19

Our guest for this episode of Talking Precision Medicine is Liang Schweizer from HiFiBiO Therapeutics - one of the most exciting young biotechs out there. They have built a discovery engine encompassing single cell, immune profiling and machine learning.

Visit TPM E23 for highlights and links from this episode.

Read moreCollapse

Ethics and Policies of Precision Medicine on the Global Stage | Talking Precision Medicine #22

Season 3 · Episode 6

Thursday, November 19, 2020 • Duration 49:32

Our guests for this episode of Talking Precision Medicine are Elissa Prichep and Cameron Fox of the World Economic Forum. Elissa and Cameron take us through the W.E.F’s precision medicine initiative, and explain how anticipating ethical tensions is key to envisioning policies for precision medicine across the globe.

Visit TPM E22 for highlights and links from this episode.

Read moreCollapse

Rebooting generics to fight cancer | Talking Precision Medicine #21

Season 3 · Episode 5

Monday, August 31, 2020 • Duration 51:12

Reboot Rx is a different kind of biotech startup. Reboot’s mission is to find generic non-cancer drugs that can benefit cancer patients quickly and affordably. And as a not-for-profit, Reboot can stay focused on its mission. Given the number of paradigms Reboot hopes to shift at once, we decided to talk with all three co-founders: CEO Laura Kleiman, COO & CTO Pradeep Mangalath and CSO Catherine Del Vecchio Fitz. Each one provides perspective on their part of the puzzle.

Visit TPM E21 for highlights and links from this episode.

Read moreCollapse

Talking Precision Medicine – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

Talking Precision Medicine – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Shared links between episodes and podcasts

Other92

LinkedIn15

Goodreads4

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

Other92

LinkedIn15

Goodreads4